Finger-Prick Blood Test Could Revolutionize Alzheimer’s Research

A new NIHR-supported international study demonstrates that Alzheimer’s disease biomarkers can be accurately detected using simple finger-prick blood samples collected at home, without refrigeration or processing. Published in Nature Medicine, the DROP-AD project involved 337 participants across seven European centers, including the University of Exeter, validating that key markers such as p-tau217, GFAP, and NfL closely match traditional blood and spinal fluid tests.

Participants successfully self-collected samples, showing the method’s potential for remote testing and large-scale research. Accuracy in detecting Alzheimer’s pathology reached 86%, highlighting the approach as a minimally invasive alternative to brain scans or spinal taps.

Researchers emphasize the technique could broaden access to diverse and underserved populations, facilitate early detection, and support studies in other neurodegenerative conditions. While promising, further research and validation are required before clinical implementation.

This breakthrough underscores the value of NIHR infrastructure in enabling globally collaborative biomedical research.

07-01-2026